Moreover, the application of AI tools to develop small-molecule inhibitors targeting MBD2 [94], as well as other demethylases and demethylase-associated proteins, is crucial for advancing therapeutic strategies in autoimmune diseases. Here, MBD2 is linked to autoimmune disease.